It has also been shown that desipramine, a NRI, still exerts an AD-like effect in 5HT1A receptor knockout mice despite reduced baseline immobility in the tail suspension test (Mayorga et al., 2001). This evidence concerns the gene HTR1A and Alzheimer disease.